The company has partnered with Memorial Sloan Kettering to support accelerated antibody design for potential pediatric cancer therapies that would take discovery from months to weeks.
The company has partnered with Memorial Sloan Kettering to support accelerated antibody design for potential pediatric cancer therapies that would take discovery from months to weeks.